0001654954-22-005373.txt : 20220425 0001654954-22-005373.hdr.sgml : 20220425 20220425161358 ACCESSION NUMBER: 0001654954-22-005373 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220419 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220425 DATE AS OF CHANGE: 20220425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zivo Bioscience, Inc. CENTRAL INDEX KEY: 0001101026 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870699977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40449 FILM NUMBER: 22849818 BUSINESS ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 BUSINESS PHONE: (248) 452 9866 MAIL ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: WESTERN GLORY HOLE INC DATE OF NAME CHANGE: 19991215 8-K 1 zivo_8k.htm FORM 8-K zivo_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 19, 2022

 

ZIVO BIOSCIENCE, INC.

(Exact name of Registrant as Specified in Its Charter)

 

Nevada

 

000-30415

 

87-0699977

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

    

21 East Long Lake Road, Suite 100,

Bloomfield Hills, Michigan

 

48304

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (248) 452-9866

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

ZIVO

 

The Nasdaq Stock Market

Warrants to purchase shares of Common

Stock, par value $0.001 per share

 

ZIVOW

 

The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On April 19, 2022, Zivo Bioscience, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the period ended December 31, 2021 (the “Form 10-K”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission.

 

The Notice had no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. The Notice provided that the Company must submit a plan to regain compliance with Nasdaq Listing Rule 5250(c)(1).

 

The Company fully regained compliance with the Nasdaq continued listing requirements as a result of filing the Form 10-K on April 22, 2022, which eliminated the need for the Company to submit a formal plan to regain compliance. On April 25, 2022, the Company received a Notice from Nasdaq confirming that the Company had regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the matter was closed.

 

A press release, dated April 25, 2022, disclosing the Company’s receipt of the Nasdaq notification letter is attached as Exhibit 99.1 and is furnished herewith.

 

Item 9.01. Financial Statements and Exhibits.  

 

(d)

Exhibits

 

99.1

 

Press Release, dated April 25, 2022.

104

 

Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.

 

 

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ZIVO BIOSCIENCE, INC.

 

 

 

 

 

Dated: April 25, 2022

By:

/s/ Keith Marchiando

 

 

 

Keith Marchiando

Chief Financial Officer, Secretary and Treasurer

 

 

 

3

 

 EX-99.1 2 zivo_ex991.htm EX-99.1 zivo_ex991.htm

EXHIBIT 99.1

 

Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq

 

BLOOMFIELD HILLS, Mich., (April 25, 2022) – ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that it received a Notice from Nasdaq that the Company has regained compliance of Nasdaq Listing Rule 5250(c)(1).

 

On April 19, 2022, the Company received a standard notice of noncompliance from Nasdaq indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission.

 

On April 22, 2022, the Company fully regained compliance with the Nasdaq continued listing requirements as a result of filing the Form 10-K. On April 25, 2022, the Company received a Notice from Nasdaq confirming that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the matter was closed.

 

About Zivo Bioscience, Inc.

 

Zivo Bioscience is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Please visit www.zivobioscience.com for more information.

 

Contacts:

 

ZIVO Bioscience, Inc.

Keith Marchiando, Chief Financial Officer

(248) 452-9866 x 130

kmarchiando@zivobioscience.com

 

LHA Investor Relations

Tirth T. Patel

(212) 201-6614

tpatel@lhai.com

 

# # #

 EX-101.SCH 3 zivo-20220419.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 zivo-20220419_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Incorporation State Country Code Entity Tax Identification Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Entity File Number Entity Address State Or Province City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address Postal Zip Code EX-101.CAL 5 zivo-20220419_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 zivo-20220419_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 zivo-20220419_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Apr. 19, 2022
Cover [Abstract]  
Entity Registrant Name ZIVO BIOSCIENCE, INC.
Entity Central Index Key 0001101026
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Apr. 19, 2022
Entity Incorporation State Country Code NV
Entity Tax Identification Number 87-0699977
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity File Number 000-30415
Entity Address State Or Province MI
City Area Code 248
Local Phone Number 452-9866
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol ZIVO
Security Exchange Name NASDAQ
Entity Address Address Line 1 21 East Long Lake Road
Entity Address Address Line 2 Suite 100
Entity Address City Or Town Bloomfield Hills
Entity Address Postal Zip Code 48304
XML 9 zivo_8k_htm.xml IDEA: XBRL DOCUMENT 0001101026 2022-04-19 2022-04-19 iso4217:USD shares iso4217:USD shares 0001101026 false 8-K 2022-04-19 ZIVO BIOSCIENCE, INC. NV 000-30415 87-0699977 21 East Long Lake Road Suite 100 Bloomfield Hills MI 48304 248 452-9866 false false false false Common Stock, par value $0.001 per share ZIVO NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://zivo.com/role/Cover Cover Cover 1 false false All Reports Book All Reports zivo_8k.htm zivo-20220419.xsd zivo-20220419_cal.xml zivo-20220419_def.xml zivo-20220419_lab.xml zivo-20220419_pre.xml zivo_ex991.htm http://xbrl.sec.gov/dei/2021q4 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "zivo_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "zivo-20220419_cal.xml" ] }, "definitionLink": { "local": [ "zivo-20220419_def.xml" ] }, "inline": { "local": [ "zivo_8k.htm" ] }, "labelLink": { "local": [ "zivo-20220419_lab.xml" ] }, "presentationLink": { "local": [ "zivo-20220419_pre.xml" ] }, "schema": { "local": [ "zivo-20220419.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "zivo", "nsuri": "http://zivo.com/20220419", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zivo_8k.htm", "contextRef": "From2022-04-19to2022-04-19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://zivo.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zivo_8k.htm", "contextRef": "From2022-04-19to2022-04-19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://zivo.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001654954-22-005373-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-005373-xbrl.zip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end